B. Vaccine Code Updates
1) COVID-19 Potential Pre-EUA Vaccine Code Additions and Updates:
COVID-19 Vaccine Codes and Crosswalks for one additional vaccine have been included in this release in anticipation of potential vaccine availability under Emergency Use Authorization (EUA). These codes will become effective if and only when the Food and Drug Administration (FDA) authorizes use of COVID-19 vaccine(s) under an EUA and ACIP votes to recommend the vaccines. The advance release of these codes is intended to help end user organizations prepare their systems ahead of vaccine distribution.
The CVX codes are listed as active. If EUA authorization and ACIP recommendation are not received, the codes will be inactivated. The NDC codes are currently listed by the FDA as “unauthorized” and these NDC codes will be activated upon receipt of an EUA authorization.
A separate downloadable table of just COVID-19 codes is also available on the CDC website vaccine code sets page and has been updated to reflect new NDCs for the COVID-19 vaccine and the new CPT codes.
https://www.cdc.gov/vaccines/programs/iis/code-sets.html
The AMA COVID-19 CPT codes for these potential EUA vaccines are also available and included in the CPT to CVX crosswalk downloadable file. American Medical Association (AMA) COVID-19 CPT® vaccine product and administration codes are available on the AMA web site:
https://www.ama-assn.org/practice-management/cpt/covid-19-cpt-vaccine-and-immunization-codes
The codes and crosswalks for candidate COVID-19 vaccines will continue to be released in phases as the late-stage clinical trials for candidate vaccines progress.
One potential new EUA candidate vaccine is included in this release as follows:
Product Name: Novavax COVID-19 Vaccine: The CVX Code and Product are new in this release. This new vaccine is still pending EUA authorization. The codes are provided in advance.
CPT and NDC codes have been added. No EUA Recipient Fact Sheet codes have been added to the VIS code set at this time.
- CVX Code = 211, “SARS-COV-2 (COVID-19) vaccine, Subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL per dose”
- MVX Code = NVX, “Novavax, Inc.”
- Product/Tradename = “Novavax COVID-19 Vaccine”
- CPT Code = 91304, “Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage, for intramuscular use”
- NDC Unit of Use: NDC10 = 80631-100-01, NDC11 = 80631-0100-01, “COVID-19 vaccine, Subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL”, Presentation: MULTI-DOSE VIAL, 10 DOSES
- NDC Unit of Sale: NDC10 = 80631-100-10, NDC11 = 80631-0100-10, “COVID-19 vaccine, Subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL”, Presentation: CARTON, 10 MULTI-DOSE VIALS
2) Other Updates – Not Covid Related
The following CPT to CVX Correction was made:- Mapping of CPT Code 90690 to CVX 190, “Typhoid conjugate vaccine (non-US)” removed. Non-US vaccines are not assigned CPT codes.
